Related Experiment Video
Updated: May 28, 2025

E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
Published on: August 1, 2019
Prevalence of Patient Knowledge Gaps Regarding the Purpose of Their Cardiometabolic Medications
Alexander Chaitoff1,2,3, Alexander R Zheutlin4, Miguel Linares5,6
1Veterans Affairs Center for Clinical Management Research, Veterans Affairs Ann Arbor Healthcare System, Ann Arbor, MI, USA. amchait@med.umich.edu.
Background:
Patient knowledge regarding why they are prescribed their medications is paramount for the delivery of quality and patient-centered cardiometabolic care.
Objective:
To generate national estimates of the proportion of patients who do not know why they are taking their anti-hypertensive, anti-diabetes, or anti-lipid medications.
Design:
Cross-sectional study using data from the National Health and Nutrition Examination Survey from January 2013 through March 2020.
Participants:
Non-institutionalized adults in the United States.
Main Measures:
Medication use was ascertained by respondent self-report and pill bottle review of their anti-hypertensive, anti-diabetes, or anti-lipid medications. The primary outcome was the proportion of respondents with a knowledge deficiency about why they were taking their respective medications defined by respondents reporting (1) they did not know why or (2) an incorrect indication for why they were taking each medication. We also report knowledge deficiency prevalences stratified by respondent characteristics and use multivariable logistic regression analysis to assess for relationship between respondent characteristics and odds of having a knowledge deficiency.
Key Results:
4.9% (95% confidence interval [CI] 4.0-5.6%, n=391) of respondents on cardiometabolic medications had ≥ 1 knowledge deficiency, which corresponds to approximately 3,152,243 US adults. This was driven most strongly by knowledge deficiencies in anti-hypertensive medication use (4.5%, 95% CI 3.7-5.3%). There were large variations in knowledge deficiency prevalence by respondent characteristics. Most notably, 12.9% (95% CI 9.8-16.0%) of adults ≥ 80 years and 12.2% (95% CI 8.6-16.0%) of adults taking ≥ 10 medication had a knowledge deficiency. Of older adults with polypharmacy (≥ 5 prescriptions), 11.2% (95% CI 8.9-13.5%) > 65 years and 15.8% (95% CI 11.5-20.2%) > 80 years had a knowledge deficiency.
Conclusions:
Most adults report a plausible reason for their use of their cardiometabolic medications. However, the prevalence of having a knowledge deficiency varied greatly by respondent demographic and health characteristics.
Related Concept Videos
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Health Literacy
Errors occurring during blood pressure monitoring
Several factors...
Heart Failure Drugs: β-Blockers
Barriers to Effective Communication II
Cultural barriers:
Differences in values, beliefs, religion, knowledge, and tradition can significantly impact communication. Awareness of nonverbal cues is critical, especially when conversing with a patient from a different culture. What appears appropriate in one culture may be inappropriate in another.
Semantic barriers:
As a result of their tendency to use...
Cardiovascular Drugs: Classification based on Therapeutic Indications

